!!TOP!! Download Gce Results 2023 Pdf

The Corporate Scorecard reports the annual snapshot of results achieved by the World Bank Group, including results and performance indicators of the World Bank, International Finance Corporation (IFC), and Multilateral Investment Guarantee Agency (MIGA).

Results Briefs are short presentations of results that have been achieved with World Bank support. They describe the challenges, solutions and results achieved and provide information on financing instruments and beneficiaries.

Download Gce Results 2023 Pdf

DOWNLOAD 🔥 https://urloso.com/2y3yy5 🔥

Treasury sells bills, notes, bonds, FRNs, and TIPS at regularly scheduled auctions. Refer to the auction announcements & results press releases for more information. Follow the links below to get the latest information on:

Note: 2023 student data files, summary data files, and preliminary student performance reports (SPRs) were made available to districts in June; finalized SPRs and school- and district-level reports were made available in July. Districts and schools may share confidential individual student performance reports with parents and may use aggregated and individual student level results internally for informational and planning purposes as soon as they are received.

See average score results for selected student groups through the drop-down menu selection below. Symbols in the figure indicate the score change between two sets of assessment years: from 2012 to 2020 and from 2020 to 2023. For example, in the figure below for race/ethnicity, the gray diamonds indicate that the 2020 reading score was not significantly different from the 2012 score for any racial/ethnic group with reportable results, and the down arrows indicate that 2023 reading scores declined for White and Black students and for students of Two or More Races in comparison to 2020.

The average reading score in 2023 for those students who reported reading for fun on their own almost every day was 275, which was higher than the scores for students who reported other levels of frequency for reading on their own time. See a data table with average score results.

Since the 1970s, the NAEP long-term trend assessments have been administered to monitor the academic performance of students across three age levels (9-, 13-, and 17-year-old students). This report mainly focuses on the comparison of age 13 students (typically in grade 8) between 2020 and 2023. A report card summarizing results for 9- and 13-year-old students across all administrations back to the 1970s is forthcoming.

The instruments and methodologies of LTT and main NAEP assessment programs are different; therefore, direct comparisons between the LTT results presented in this report and the assessment results presented in other main NAEP reports are not possible. Read more about the differences between long-term trend and main NAEP assessments.

NOTE: The NAEP long-term trend (LTT) reading and mathematics scales range from 0 to 500. Because the scales were developed separately for each subject, comparisons cannot be made from one subject to another. Black includes African American. Hispanic includes Latino. Race categories exclude Hispanic origin. The information about National School Lunch Program (NSLP) variable is based on available school records. If school records were not available, the student was classified as "Information not available." The category "students with disabilities" includes students identified as having either an Individualized Education Program (IEP) or protection under Section 504 of the Rehabilitation Act of 1973. The results for students with disabilities and English learners are based on students who were assessed and cannot be generalized to the total population of such students. See more information about student group variables. Detail may not sum to totals because of rounding or the omission of categories. Although the estimates (e.g., average scores or percentages) are shown as rounded numbers in the charts, the positions of the data points in the graphics are based on the unrounded numbers. Unrounded numbers were used for calculating the differences between the estimates, and for the statistical comparison test when the estimates were compared to each other. Not all apparent differences between estimates are statistically significant. NAEP reports results using widely accepted statistical standards; findings are reported based on a statistical significance level set at .05, with appropriate adjustments for multiple comparisons. Only those differences that are found to be statistically significant are referred to as "higher" or "lower."

The RFI results make it clear: America needs to produce more semiconductors. Congress must pass funding for domestic semiconductor production, such as the U.S. Innovation and Competition Act, to solve our supply challenges for the long term.

MCAS test results from the last six years are available below. Click on the year to view results and interpretive materials. To view results from prior years, browse School and District Profiles or contact Student Assessment Services at mcas@doe.mass.edu .

Apportionment is the process of dividing the 435 memberships, or seats, in the U.S. House of Representatives among the 50 states. At the conclusion of each decennial census, the results are used to calculate the number of seats to which each state is entitled. Each of the 50 states is entitled to a minimum of one seat in the U.S. House of Representatives.

The results of this exploratory consultation gave us a direction on where to dig deeper and engage in a thorough reflection on how to unleash the Single Market for digital networks and make our connectivity more secure and future-proof.

The structure of the excel file is similar to the published results. The questions are in row 4, while the individual contributions are in the rows below it. The contributions are split into 3 worksheets (Content, Content 1 and Content 2), each containing one third of the responses. The worksheets are not linked, therefore if you change the order of the rows by sorting the responses by certain conditions, this will only affect one worksheet.

This document describes the definitions for results data elements submitted to ClinicalTrials.gov for interventional studies (clinical trials) and observational studies. These definitions are mostly adapted from 42 CFR Part 11.Data element entries are annotated with symbols to indicate generally what information is required to be submitted and under which circumstances. The responsible party must ensure that the information provided complies with any applicable laws, regulations, or policies. For more information about various requirements and definitions of regulatory terms under 42 CFR Part 11, see Support Materials.Note: The term "clinical study" is used to refer to both interventional and observational studies. The term "participant" is used to refer to a human subject.

Delay Results Type [*] : Select one Certify Initial Approval: Trial studies an FDA-regulated drug product (including a biological product) or device product that was not approved, licensed or cleared by FDA for any use before the Primary Completion Date of the trial, and the sponsor intends to continue with product development and is either seeking, or may at a future date seek, FDA approval, licensure, or clearance of the drug product (including a biological product) or device product under study. Certify New Use: Trial studies an FDA-regulated drug product (including a biological product) or device product that previously has been approved, licensed, or cleared, for which the manufacturer is the sponsor of the trial and for which an application or premarket notification seeking approval, licensure, or clearance of the use being studied (which is not included in the labeling of the approved, licensed, or cleared drug, product (including a biologic product) or device product) has been filed or will be filed within one year with FDA. Extension: Request, for good cause, an extension of the deadline for submitting results information Note: If a responsible party who is both the manufacturer of the drug product (including a biological product) or device product studied in an applicable clinical trial and the sponsor of the applicable clinical trial submits a certification under "Certify New Use," that responsible party must submit such a certification for each applicable clinical trial that meets the following criteria: (1) the applicable clinical trial is required to be submitted in an application or premarket notification seeking approval, licensure, or clearance of a new use; (2) the applicable clinical trial studies the same drug product (including a biological product) or device product for the same use as studied in the applicable clinical trial for which the initial certification was submitted. [42 U.S.C. 282 (j)(3)(E)(v)(II) and 42 CFR 11.44(b)(3)]

Requested Submission Date [*] (Required when Delay Results Type is "Extension.")

Definition: Estimate of the date on which the clinical study results information will be submitted, if the Delay Results Type is "Extension".

Explanation [*] (Required when Delay Results Type is "Extension.")

Definition: Description of the reason(s) why clinical study results information cannot be provided according to the deadline, with sufficient detail to justify good cause for the extension and to allow for the evaluation of the request. Such detail includes reason(s) for the extension and proposed requested submission date, steps that will be taken to meet the requested submission date, a description of mitigating steps to avoid future delay, and any other information needed to address the criteria in Section III of the NIH Good Cause Extension Request Process and Criteria document. Note that "pending publication" and delays in data analysis without sufficient explanation are not considered good cause for an extension.